Cinobufagin suppresses T-ALL via USP7-Mediated inhibition of NOTCH1/PI3K signaling pathways
Jiahe Wang(Second Military Medical University), Liang Zhang(Nanjing University of Chinese Medicine), Yujie Xiang(Nanjing University of Chinese Medicine), Chen Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Ye(East China University of Science and Technology), Hong Zhang(Ocean University of China), Ying Wang(Hebei Medical University), Siyu Cheng(Nanjing University of Chinese Medicine), Huimin Wu(Huazhong University of Science and Technology), Yiran Cheng(Sichuan Agricultural University)
Cited by 0
Related Papers
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k